The global Touch Activated Phlebotomy Device market was valued at US$ 249 million in 2025 and is anticipated to reach US$ 580 million by 2032, at a CAGR of 12.3% from 2026 to 2032.

Touch Activated Phlebotomy Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Touch Activated Phlebotomy Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Touch Activated Phlebotomy Device refers to a venous blood collection device engineered around touch-triggered, often one-hand activation. It typically integrates needle protection, puncture activation, blood return indication/feedback, hemostasis support, and safety lockout in a single system to reduce procedural steps while improving consistency and safety. The device can be configured for vacuum tube collection, butterfly sets/extension tubing, or dedicated connector interfaces, serving routine laboratory phlebotomy and selected bedside sampling workflows. Its core value lies in touch-activated mechanics and closed or semi-closed fluid pathways that minimize exposed needle time and blood splashes, lowering needlestick risk, improving patient comfort, and enabling more standardized, efficient, and compliant phlebotomy operations.In 2025, global Touch Activated Phlebotomy Deviceproduction reached approximately 24.9 million units and price is about 10 usd/unit.The average gross profit margin of this product is 55%.

As healthcare providers strengthen occupational exposure prevention, infection control, and procedural standardization, safety upgrades in phlebotomy have become a firm requirement. Touch-activated phlebotomy devices align with the need to reduce steps, minimize exposure, and improve consistency—especially in high-throughput settings such as emergency departments, outpatient draw stations, and centralized pre-analytical workflows. Workforce shifts and rising training costs further favor intuitive, repeatable devices that reduce dependence on individual technique. In many institutions, “safe phlebotomy” is evolving into a system-level procurement and governance theme, driving upgrades from single consumables toward integrated offerings that combine devices, compatible disposables, and service—expanding the commercial runway for suppliers with interface ecosystems and scalable delivery capabilities.

Challenges center on clinical adaptability, cost sensitivity, and compliance validation. Venous variability, insertion angle, and activation force can influence first-stick success and patient experience; the device must deliver stable performance across patient populations and departments. Any issues such as insensitive triggering, unclear blood return feedback, or connector incompatibility can increase procedure time and complaints. Phlebotomy supplies are also high-frequency and cost-sensitive, so suppliers must balance safety upgrades with tight cost control and reliable supply. In addition, products incorporating needle safety mechanisms require robust quality systems, regulatory compliance, and real-world usability validation; inadequate training or inconsistent use can blunt the intended safety benefits and undermine repurchase and adoption within the hospital.

Demand is shifting from “usable” to “controllable, traceable, and standardized.” Providers increasingly focus on the entire pre-analytical quality chain—patient identification, collection consistency, hemolysis/clotting control, sample logistics efficiency, and documentation of occupational exposure events. Therefore, touch-activated devices must not only be safe and easy to use, but also fit seamlessly into vacuum tube systems, phlebotomy carts, and specimen management workflows. Health-check centers and IVD-related service settings emphasize throughput and low error rates, favoring solutions that shorten cycle time and reduce rework. For populations with difficult venous access (pediatrics, geriatrics, oncology), the market leans toward variants with enhanced control and clear visual/functional feedback. Overall, product portfolios are evolving toward scenario-specific series and a complementary consumable ecosystem.

Key upstream inputs include medical-grade stainless-steel cannulae and bevel grinding, medical polymers for hubs/housings and activation structures, elastomers and seals for valves and leak prevention, transparent materials for observation windows, and connector components compatible with vacuum tubes or extension sets. For safety lockout and anti-rebound mechanisms, consistency of micro-springs, latches, and precision assembly determines activation feel and reliability. Because the device contacts blood directly or operates in near-blood environments, biocompatibility, sterilization compatibility, extractables/leachables control, and batch stability are critical. At scale, injection mold accuracy, automated assembly yield, and in-line inspection capabilities become decisive. Ultimately, upstream stability and quality management translate into first-stick performance, leakage risk, and safety-mechanism reliability—forming the foundation for brand trust and long-term institutional partnerships.

This report delivers a comprehensive overview of the global Touch Activated Phlebotomy Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Touch Activated Phlebotomy Device. The Touch Activated Phlebotomy Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Touch Activated Phlebotomy Device market comprehensively. Regional market sizes by Type, by Application, by Needlestick, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Touch Activated Phlebotomy Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Touch Activated Phlebotomy Device Market Report

Report Metric	Details
Report Name	Touch Activated Phlebotomy Device Market
Accounted market size in 2025	US$ 249 million
Forecasted market size in 2032	US$ 580 million
CAGR	12.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Peripheral Venous Phlebotomy Central Line Sampling Support Other
Segment by Needlestick	Passive Safety Active Safet
Segment by Safety Mechanism	Passive/Auto-Engage User-Activated Mechanisms Other
by Application	Hospitals Diagnostics/Reference Labs Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	BD, Greiner Bio-One, Terumo, Nipro, B. Braun, Sarstedt, Cardinal Health, Medline, ICU Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Needlestick, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Touch Activated Phlebotomy Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Touch Activated Phlebotomy Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Touch Activated Phlebotomy Device Market growing?

Ans: The Touch Activated Phlebotomy Device Market witnessing a CAGR of 12.3% during the forecast period 2026-2032.

What is the Touch Activated Phlebotomy Device Market size in 2032?

Ans: The Touch Activated Phlebotomy Device Market size in 2032 will be US$ 580 million.

Who are the main players in the Touch Activated Phlebotomy Device Market report?

Ans: The main players in the Touch Activated Phlebotomy Device Market are BD, Greiner Bio-One, Terumo, Nipro, B. Braun, Sarstedt, Cardinal Health, Medline, ICU Medical

What are the Application segmentation covered in the Touch Activated Phlebotomy Device Market report?

Ans: The Applications covered in the Touch Activated Phlebotomy Device Market report are Hospitals, Diagnostics/Reference Labs, Other

What are the Type segmentation covered in the Touch Activated Phlebotomy Device Market report?

Ans: The Types covered in the Touch Activated Phlebotomy Device Market report are Peripheral Venous Phlebotomy, Central Line Sampling Support, Other

1 Touch Activated Phlebotomy Device Market Overview

1.1 Product Definition

1.2 Touch Activated Phlebotomy Device by Type

1.2.1 Global Touch Activated Phlebotomy Device Market Value by Type: 2025 vs 2032

1.2.2 Peripheral Venous Phlebotomy

1.2.3 Central Line Sampling Support

1.2.4 Other

1.3 Touch Activated Phlebotomy Device by Needlestick

1.3.1 Global Touch Activated Phlebotomy Device Market Value by Needlestick: 2025 vs 2032

1.3.2 Passive Safety

1.3.3 Active Safet

1.4 Touch Activated Phlebotomy Device by Safety Mechanism

1.4.1 Global Touch Activated Phlebotomy Device Market Value by Safety Mechanism: 2025 vs 2032

1.4.2 Passive/Auto-Engage

1.4.3 User-Activated Mechanisms

1.4.4 Other

1.5 Touch Activated Phlebotomy Device by Application

1.5.1 Global Touch Activated Phlebotomy Device Market Value by Application: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Diagnostics/Reference Labs

1.5.4 Other

1.6 Global Touch Activated Phlebotomy Device Market Size Estimates and Forecasts

1.6.1 Global Touch Activated Phlebotomy Device Revenue 2021–2032

1.6.2 Global Touch Activated Phlebotomy Device Sales 2021–2032

1.6.3 Global Touch Activated Phlebotomy Device Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Touch Activated Phlebotomy Device Market Competition by Manufacturers

2.1 Global Touch Activated Phlebotomy Device Sales Market Share by Manufacturers (2021–2026)

2.2 Global Touch Activated Phlebotomy Device Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Touch Activated Phlebotomy Device Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Touch Activated Phlebotomy Device, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Touch Activated Phlebotomy Device, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Touch Activated Phlebotomy Device, Product Types and Applications

2.7 Global Key Manufacturers of Touch Activated Phlebotomy Device, Date of Entry into the Industry

2.8 Global Touch Activated Phlebotomy Device Market Competitive Situation and Trends

2.8.1 Global Touch Activated Phlebotomy Device Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Touch Activated Phlebotomy Device Players Market Share by Revenue

2.8.3 Global Touch Activated Phlebotomy Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Touch Activated Phlebotomy Device Market Scenario by Region

3.1 Global Touch Activated Phlebotomy Device Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Touch Activated Phlebotomy Device Sales by Region: 2021–2032

3.2.1 Global Touch Activated Phlebotomy Device Sales by Region: 2021–2026

3.2.2 Global Touch Activated Phlebotomy Device Sales by Region: 2027–2032

3.3 Global Touch Activated Phlebotomy Device Revenue by Region: 2021–2032

3.3.1 Global Touch Activated Phlebotomy Device Revenue by Region: 2021–2026

3.3.2 Global Touch Activated Phlebotomy Device Revenue by Region: 2027–2032

3.4 North America Touch Activated Phlebotomy Device Market Facts & Figures by Country

3.4.1 North America Touch Activated Phlebotomy Device Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Touch Activated Phlebotomy Device Sales by Country (2021–2032)

3.4.3 North America Touch Activated Phlebotomy Device Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Touch Activated Phlebotomy Device Market Facts & Figures by Country

3.5.1 Europe Touch Activated Phlebotomy Device Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Touch Activated Phlebotomy Device Sales by Country (2021–2032)

3.5.3 Europe Touch Activated Phlebotomy Device Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Touch Activated Phlebotomy Device Market Facts & Figures by Region

3.6.1 Asia Pacific Touch Activated Phlebotomy Device Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Touch Activated Phlebotomy Device Sales by Region (2021–2032)

3.6.3 Asia Pacific Touch Activated Phlebotomy Device Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Touch Activated Phlebotomy Device Market Facts & Figures by Country

3.7.1 Latin America Touch Activated Phlebotomy Device Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Touch Activated Phlebotomy Device Sales by Country (2021–2032)

3.7.3 Latin America Touch Activated Phlebotomy Device Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Touch Activated Phlebotomy Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Touch Activated Phlebotomy Device Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Touch Activated Phlebotomy Device Sales by Country (2021–2032)

3.8.3 Middle East and Africa Touch Activated Phlebotomy Device Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Touch Activated Phlebotomy Device Sales by Type (2021–2032)

4.1.1 Global Touch Activated Phlebotomy Device Sales by Type (2021–2026)

4.1.2 Global Touch Activated Phlebotomy Device Sales by Type (2027–2032)

4.1.3 Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021–2032)

4.2 Global Touch Activated Phlebotomy Device Revenue by Type (2021–2032)

4.2.1 Global Touch Activated Phlebotomy Device Revenue by Type (2021–2026)

4.2.2 Global Touch Activated Phlebotomy Device Revenue by Type (2027–2032)

4.2.3 Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2021–2032)

4.3 Global Touch Activated Phlebotomy Device Price by Type (2021–2032)

5 Segment by Application

5.1 Global Touch Activated Phlebotomy Device Sales by Application (2021–2032)

5.1.1 Global Touch Activated Phlebotomy Device Sales by Application (2021–2026)

5.1.2 Global Touch Activated Phlebotomy Device Sales by Application (2027–2032)

5.1.3 Global Touch Activated Phlebotomy Device Sales Market Share by Application (2021–2032)

5.2 Global Touch Activated Phlebotomy Device Revenue by Application (2021–2032)

5.2.1 Global Touch Activated Phlebotomy Device Revenue by Application (2021–2026)

5.2.2 Global Touch Activated Phlebotomy Device Revenue by Application (2027–2032)

5.2.3 Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2021–2032)

5.3 Global Touch Activated Phlebotomy Device Price by Application (2021–2032)

6 Key Companies Profiled

6.1 BD

6.1.1 BD Company Information

6.1.2 BD Description and Business Overview

6.1.3 BD Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 BD Touch Activated Phlebotomy Device Product Portfolio

6.1.5 BD Recent Developments/Updates

6.2 Greiner Bio-One

6.2.1 Greiner Bio-One Company Information

6.2.2 Greiner Bio-One Description and Business Overview

6.2.3 Greiner Bio-One Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Greiner Bio-One Touch Activated Phlebotomy Device Product Portfolio

6.2.5 Greiner Bio-One Recent Developments/Updates

6.3 Terumo

6.3.1 Terumo Company Information

6.3.2 Terumo Description and Business Overview

6.3.3 Terumo Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Terumo Touch Activated Phlebotomy Device Product Portfolio

6.3.5 Terumo Recent Developments/Updates

6.4 Nipro

6.4.1 Nipro Company Information

6.4.2 Nipro Description and Business Overview

6.4.3 Nipro Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Nipro Touch Activated Phlebotomy Device Product Portfolio

6.4.5 Nipro Recent Developments/Updates

6.5 B. Braun

6.5.1 B. Braun Company Information

6.5.2 B. Braun Description and Business Overview

6.5.3 B. Braun Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 B. Braun Touch Activated Phlebotomy Device Product Portfolio

6.5.5 B. Braun Recent Developments/Updates

6.6 Sarstedt

6.6.1 Sarstedt Company Information

6.6.2 Sarstedt Description and Business Overview

6.6.3 Sarstedt Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Sarstedt Touch Activated Phlebotomy Device Product Portfolio

6.6.5 Sarstedt Recent Developments/Updates

6.7 Cardinal Health

6.7.1 Cardinal Health Company Information

6.7.2 Cardinal Health Description and Business Overview

6.7.3 Cardinal Health Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Cardinal Health Touch Activated Phlebotomy Device Product Portfolio

6.7.5 Cardinal Health Recent Developments/Updates

6.8 Medline

6.8.1 Medline Company Information

6.8.2 Medline Description and Business Overview

6.8.3 Medline Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Medline Touch Activated Phlebotomy Device Product Portfolio

6.8.5 Medline Recent Developments/Updates

6.9 ICU Medical

6.9.1 ICU Medical Company Information

6.9.2 ICU Medical Description and Business Overview

6.9.3 ICU Medical Touch Activated Phlebotomy Device Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 ICU Medical Touch Activated Phlebotomy Device Product Portfolio

6.9.5 ICU Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Touch Activated Phlebotomy Device Industry Chain Analysis

7.2 Touch Activated Phlebotomy Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Touch Activated Phlebotomy Device Production Mode & Process Analysis

7.4 Touch Activated Phlebotomy Device Sales and Marketing

7.4.1 Touch Activated Phlebotomy Device Sales Channels

7.4.2 Touch Activated Phlebotomy Device Distributors

7.5 Touch Activated Phlebotomy Device Customer Analysis

8 Touch Activated Phlebotomy Device Market Dynamics

8.1 Touch Activated Phlebotomy Device Industry Trends

8.2 Touch Activated Phlebotomy Device Market Drivers

8.3 Touch Activated Phlebotomy Device Market Challenges

8.4 Touch Activated Phlebotomy Device Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Touch Activated Phlebotomy Device Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Touch Activated Phlebotomy Device Market Value by Needlestick (US$ Million), 2025 vs 2032

Table 3. Global Touch Activated Phlebotomy Device Market Value by Safety Mechanism (US$ Million), 2025 vs 2032

Table 4. Global Touch Activated Phlebotomy Device Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Touch Activated Phlebotomy Device Market Competitive Situation by Manufacturers in 2025

Table 6. Global Touch Activated Phlebotomy Device Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Touch Activated Phlebotomy Device Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Touch Activated Phlebotomy Device Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Touch Activated Phlebotomy Device Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Touch Activated Phlebotomy Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Touch Activated Phlebotomy Device, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Touch Activated Phlebotomy Device, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Touch Activated Phlebotomy Device, Product Types and Applications

Table 14. Global Key Manufacturers of Touch Activated Phlebotomy Device, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Touch Activated Phlebotomy Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Touch Activated Phlebotomy Device Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Touch Activated Phlebotomy Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Touch Activated Phlebotomy Device Sales by Region (K Units), 2021–2026

Table 20. Global Touch Activated Phlebotomy Device Sales Market Share by Region (2021–2026)

Table 21. Global Touch Activated Phlebotomy Device Sales by Region (K Units), 2027–2032

Table 22. Global Touch Activated Phlebotomy Device Sales Market Share by Region (2027–2032)

Table 23. Global Touch Activated Phlebotomy Device Revenue by Region (US$ Million), 2021–2026

Table 24. Global Touch Activated Phlebotomy Device Revenue Market Share by Region (2021–2026)

Table 25. Global Touch Activated Phlebotomy Device Revenue by Region (US$ Million), 2027–2032

Table 26. Global Touch Activated Phlebotomy Device Revenue Market Share by Region (2027–2032)

Table 27. North America Touch Activated Phlebotomy Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Touch Activated Phlebotomy Device Sales by Country (K Units), 2021–2026

Table 29. North America Touch Activated Phlebotomy Device Sales by Country (K Units), 2027–2032

Table 30. North America Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2021–2026

Table 31. North America Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Touch Activated Phlebotomy Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Touch Activated Phlebotomy Device Sales by Country (K Units), 2021–2026

Table 34. Europe Touch Activated Phlebotomy Device Sales by Country (K Units), 2027–2032

Table 35. Europe Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Touch Activated Phlebotomy Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Touch Activated Phlebotomy Device Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Touch Activated Phlebotomy Device Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Touch Activated Phlebotomy Device Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Touch Activated Phlebotomy Device Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Touch Activated Phlebotomy Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Touch Activated Phlebotomy Device Sales by Country (K Units), 2021–2026

Table 44. Latin America Touch Activated Phlebotomy Device Sales by Country (K Units), 2027–2032

Table 45. Latin America Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Touch Activated Phlebotomy Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Touch Activated Phlebotomy Device Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Touch Activated Phlebotomy Device Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Touch Activated Phlebotomy Device Revenue by Country (US$ Million), 2027–2032

Table 52. Global Touch Activated Phlebotomy Device Sales (K Units) by Type (2021–2026)

Table 53. Global Touch Activated Phlebotomy Device Sales (K Units) by Type (2027–2032)

Table 54. Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021–2026)

Table 55. Global Touch Activated Phlebotomy Device Sales Market Share by Type (2027–2032)

Table 56. Global Touch Activated Phlebotomy Device Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Touch Activated Phlebotomy Device Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2021–2026)

Table 59. Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2027–2032)

Table 60. Global Touch Activated Phlebotomy Device Price (US$/Unit) by Type (2021–2026)

Table 61. Global Touch Activated Phlebotomy Device Price (US$/Unit) by Type (2027–2032)

Table 62. Global Touch Activated Phlebotomy Device Sales (K Units) by Application (2021–2026)

Table 63. Global Touch Activated Phlebotomy Device Sales (K Units) by Application (2027–2032)

Table 64. Global Touch Activated Phlebotomy Device Sales Market Share by Application (2021–2026)

Table 65. Global Touch Activated Phlebotomy Device Sales Market Share by Application (2027–2032)

Table 66. Global Touch Activated Phlebotomy Device Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Touch Activated Phlebotomy Device Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2021–2026)

Table 69. Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2027–2032)

Table 70. Global Touch Activated Phlebotomy Device Price (US$/Unit) by Application (2021–2026)

Table 71. Global Touch Activated Phlebotomy Device Price (US$/Unit) by Application (2027–2032)

Table 72. BD Company Information

Table 73. BD Description and Business Overview

Table 74. BD Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. BD Touch Activated Phlebotomy Device Product

Table 76. BD Recent Developments/Updates

Table 77. Greiner Bio-One Company Information

Table 78. Greiner Bio-One Description and Business Overview

Table 79. Greiner Bio-One Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Greiner Bio-One Touch Activated Phlebotomy Device Product

Table 81. Greiner Bio-One Recent Developments/Updates

Table 82. Terumo Company Information

Table 83. Terumo Description and Business Overview

Table 84. Terumo Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Terumo Touch Activated Phlebotomy Device Product

Table 86. Terumo Recent Developments/Updates

Table 87. Nipro Company Information

Table 88. Nipro Description and Business Overview

Table 89. Nipro Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Nipro Touch Activated Phlebotomy Device Product

Table 91. Nipro Recent Developments/Updates

Table 92. B. Braun Company Information

Table 93. B. Braun Description and Business Overview

Table 94. B. Braun Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. B. Braun Touch Activated Phlebotomy Device Product

Table 96. B. Braun Recent Developments/Updates

Table 97. Sarstedt Company Information

Table 98. Sarstedt Description and Business Overview

Table 99. Sarstedt Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. Sarstedt Touch Activated Phlebotomy Device Product

Table 101. Sarstedt Recent Developments/Updates

Table 102. Cardinal Health Company Information

Table 103. Cardinal Health Description and Business Overview

Table 104. Cardinal Health Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. Cardinal Health Touch Activated Phlebotomy Device Product

Table 106. Cardinal Health Recent Developments/Updates

Table 107. Medline Company Information

Table 108. Medline Description and Business Overview

Table 109. Medline Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. Medline Touch Activated Phlebotomy Device Product

Table 111. Medline Recent Developments/Updates

Table 112. ICU Medical Company Information

Table 113. ICU Medical Description and Business Overview

Table 114. ICU Medical Touch Activated Phlebotomy Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 115. ICU Medical Touch Activated Phlebotomy Device Product

Table 116. ICU Medical Recent Developments/Updates

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Touch Activated Phlebotomy Device Distributors List

Table 120. Touch Activated Phlebotomy Device Customers List

Table 121. Touch Activated Phlebotomy Device Market Trends

Table 122. Touch Activated Phlebotomy Device Market Drivers

Table 123. Touch Activated Phlebotomy Device Market Challenges

Table 124. Touch Activated Phlebotomy Device Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Authors List of This Report

List of Figures

Figure 1. Product Picture of Touch Activated Phlebotomy Device

Figure 2. Global Touch Activated Phlebotomy Device Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Touch Activated Phlebotomy Device Market Share by Type: 2025 & 2032

Figure 4. Peripheral Venous Phlebotomy Product Picture

Figure 5. Central Line Sampling Support Product Picture

Figure 6. Other Product Picture

Figure 7. Global Touch Activated Phlebotomy Device Market Value by Needlestick (US$ Million), 2021–2032

Figure 8. Global Touch Activated Phlebotomy Device Market Share by Needlestick: 2025 vs 2032

Figure 9. Passive Safety Product Picture

Figure 10. Active Safet Product Picture

Figure 11. Global Touch Activated Phlebotomy Device Market Value by Safety Mechanism (US$ Million), 2021–2032

Figure 12. Global Touch Activated Phlebotomy Device Market Share by Safety Mechanism: 2025 vs 2032

Figure 13. Passive/Auto-Engage Product Picture

Figure 14. User-Activated Mechanisms Product Picture

Figure 15. Other Product Picture

Figure 16. Global Touch Activated Phlebotomy Device Market Value by Application (US$ Million), 2021–2032

Figure 17. Global Touch Activated Phlebotomy Device Market Share by Application: 2025 & 2032

Figure 18. Hospitals

Figure 19. Diagnostics/Reference Labs

Figure 20. Other

Figure 21. Global Touch Activated Phlebotomy Device Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Touch Activated Phlebotomy Device Market Size (US$ Million), 2021–2032

Figure 23. Global Touch Activated Phlebotomy Device Sales (K Units), 2021–2032

Figure 24. Global Touch Activated Phlebotomy Device Average Price (US$/Unit), 2021–2032

Figure 25. Touch Activated Phlebotomy Device Report Years Considered

Figure 26. Touch Activated Phlebotomy Device Sales Share by Manufacturers in 2025

Figure 27. Global Touch Activated Phlebotomy Device Revenue Share by Manufacturers in 2025

Figure 28. Top 5 and Top 10 Global Touch Activated Phlebotomy Device Players: Market Share by Revenue in Touch Activated Phlebotomy Device in 2025

Figure 29. Touch Activated Phlebotomy Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 30. Global Touch Activated Phlebotomy Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 31. North America Touch Activated Phlebotomy Device Sales Market Share by Country (2021–2032)

Figure 32. North America Touch Activated Phlebotomy Device Revenue Market Share by Country (2021–2032)

Figure 33. United States Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Canada Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Europe Touch Activated Phlebotomy Device Sales Market Share by Country (2021–2032)

Figure 36. Europe Touch Activated Phlebotomy Device Revenue Market Share by Country (2021–2032)

Figure 37. Germany Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. France Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. U.K. Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Italy Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Russia Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Asia Pacific Touch Activated Phlebotomy Device Sales Market Share by Region (2021–2032)

Figure 43. Asia Pacific Touch Activated Phlebotomy Device Revenue Market Share by Region (2021–2032)

Figure 44. China Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Japan Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. South Korea Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. India Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Australia Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. China Taiwan Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Southeast Asia Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Latin America Touch Activated Phlebotomy Device Sales Market Share by Country (2021–2032)

Figure 52. Latin America Touch Activated Phlebotomy Device Revenue Market Share by Country (2021–2032)

Figure 53. Mexico Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Brazil Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Argentina Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Colombia Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Middle East and Africa Touch Activated Phlebotomy Device Sales Market Share by Country (2021–2032)

Figure 58. Middle East and Africa Touch Activated Phlebotomy Device Revenue Market Share by Country (2021–2032)

Figure 59. Turkey Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Saudi Arabia Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. UAE Touch Activated Phlebotomy Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Global Sales Market Share of Touch Activated Phlebotomy Device by Type (2021–2032)

Figure 63. Global Revenue Market Share of Touch Activated Phlebotomy Device by Type (2021–2032)

Figure 64. Global Touch Activated Phlebotomy Device Price (US$/Unit) by Type (2021–2032)

Figure 65. Global Sales Market Share of Touch Activated Phlebotomy Device by Application (2021–2032)

Figure 66. Global Revenue Market Share of Touch Activated Phlebotomy Device by Application (2021–2032)

Figure 67. Global Touch Activated Phlebotomy Device Price (US$/Unit) by Application (2021–2032)

Figure 68. Touch Activated Phlebotomy Device Value Chain

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions